Acta Dermato-Venereologica (May 2024)

Is Telemedicine Suitable for Patients with Chronic Inflammatory Skin Conditions? A Systematic Review

  • Wynanda A. van Enst,
  • Ying Chao Weng,
  • Sophie A. C. Wanten,
  • Marieke M.B. Seyger,
  • Ewout M. Baerveldt,
  • Bernd W.M. Arents,
  • Elke M.G.J. de Jong,
  • Juul M.P.A. van den Reek

DOI
https://doi.org/10.2340/actadv.v104.23901
Journal volume & issue
Vol. 104

Abstract

Read online

Telemedicine, the provision of remote healthcare, has gained prominence, accelerated by the COVID-19 pandemic. It has the potential to replace routine in-person follow-up visits for patients with chronic inflammatory skin conditions. However, it remains unclear whether telemedicine can effectively substitute in-person consultations for this patient group. This systematic review assessed the effectiveness and safety of telemedicine compared with traditional in-person care for chronic inflammatory skin diseases. A comprehensive search in various databases identified 11 articles, including 5 randomized controlled trials (RCTs) and 1 clinical controlled trial (CCT). These studies evaluated telemedicine’s impact on patients with psoriasis and atopic dermatitis, with varying methods like video consultations and digital platforms. The findings tentatively suggest that telemedicine does not seem to be inferior compared with in-person care, particularly in terms of condition severity and quality of life for patients with chronic inflammatory skin diseases. However, these results should be interpreted with caution due to the inherent uncertainties in the evidence. There are indications that telemedicine can offer benefits such as cost-effectiveness, time savings, and reduced travel distances, but it is important to recognize these findings as preliminary, necessitating further validation through more extensive research.

Keywords